I’m sure it’s not all doom and gloom but the headlines suggest otherwise
Firms owed $1.7m by OneLife Labs
OneLife Labs owes more than A$1.7 million to creditors, including $365,000 to Colombian producer Clever Leaves, as potential buyers continue to explore the acquisition of its manufacturing facility.
Health House parent hits financial wall as Melodiol enters administration
Health House parent Melodiol Global Health has entered voluntary administration, the third medicinal cannabis company to hit the financial wall in the space of six weeks.
Epsilon sets ‘roadmap’ but issues remain as firm seeks ASX return
Epsilon Healthcare has “re-established its foundation” and has a “clear roadmap for sustainable profitability”, its chairman has said.
Releaf’s new owners explore plan to bring franchisees back
The newly-formed joint venture which acquired Releaf Group assets has approached former franchisees as it looks to rebuild the network and bring disillusioned patients back into the fold.
Melodiol facing creditor and loan debts of $17m, report reveals
Troubled Melodiol Global Health has racked up A$17 million worth of debt, an initial administrator’s report has revealed, as efforts continue to sell its distribution arm, Health House.
